BioCatalystWatch
CNTXWorkspace / CNTX / OverviewCompany library
Context Therapeutics Inc. logo

Context Therapeutics Inc.

Context Therapeutics Inc. (CNTX)

Website

Price
Market cap
Next catalystQ1 2027: anticipated Phase 1b expansion, informed by Phase 1a resultsCTIM-76 — Phase 1a dose escalation and planned Phase 1b expansion · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

CTIM-76

CLDN6 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CT-202

Nectin-4 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CTIM-76

CLDN6 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CT-202

Nectin-4 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

CLDN6 × CD3 bispecific antibody

CLDN6 × CD3

PreINDP1P2P3FilingApproved
CT-202

Nectin-4 × CD3

CT-202

Nectin-4 × CD3

History / paused

MSLN × CD3

PreINDP1P2P3FilingApproved

MSLN × CD3

PreINDP1P2P3FilingApproved

MSLN × CD3

PreINDP1P2P3FilingApproved

MSLN × CD3

PreINDP1P2P3FilingApproved

MSLN × CD3

PreINDP1P2P3FilingApproved

Progesterone receptor (PR)

PreINDP1P2P3FilingApproved

Progesterone receptor (PR)

PreINDP1P2P3FilingApproved

Progesterone receptor (PR)

Progesterone receptor (PR)

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CNTX PR & News

PR & News

CNTX SEC archive